Cefepime Cefepime 613 Mg Breastfeeding
There are high number of clear evidence that breastfeeding provides best nutrition that you can give to your baby. It is also evident that lactation is good for mothers health as well. Evolution has designed breastfeeding in a way that it caters all nutritional need of your child. However modern medicine is quite new for evolution, that is why mothers body is not well prepared to filter unnecessary chemical found in medicines. It becomes a necessity to figure out which drug is safe and which drug is dangerous for your newborn while nursing. In this article we will understand function of Cefepime Cefepime 613 Mg and its suitability with breastfeeding.

What is Cefepime Cefepime 613 Mg used for?


Cefepime for injection is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: Pneumonia. ( 1.1) Empiric therapy for febrile neutropenic patients. ( 1.2) Uncomplicated and complicated urinary tract infections (including pyelonephritis). ( 1.3) Uncomplicated skin and skin structure infections. ( 1.4) Complicated intra-abdominal infections (used in combination with metronidazole) in adults. ( 1.5) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefepime for injection and other antibacterial drugs, cefepime for injection should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. ( 1.6) 1.1 Pneumonia Cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of Streptococcus pneumoniae, including cases associated with concurrent bacteremia, Pseudomonas aeruginosa, Klebsiella pneumoniae, or Enterobacter species. 1.2 Empiric Therapy for Febrile Neutropenic Patients Cefepime for injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. In patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. Insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see Clinical Studies ( 14.1)] . 1.3 Uncomplicated and Complicated Urinary Tract Infections (including pyelonephritis) Cefepime for injection is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of Escherichia coli or Klebsiella pneumoniae, when the infection is severe, or caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis, when the infection is mild to moderate, including cases associated with concurrent bacteremia with these bacteria. 1.4 Uncomplicated Skin and Skin Structure Infections Cefepime for injection is indicated in the treatment of uncomplicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes. 1.5 Complicated Intra-Abdominal Infections (used in combination with metronidazole) Cefepime for injection is indicated in the treatment of complicated intra-abdominal infections (used in combination with metronidazole) in adults caused by susceptible isolates of Escherichia coli, viridans group streptococci, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, or Bacteroides fragilis [see Clinical Studies ( 14.2)] . 1.6 Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefepime for injection and other antibacterial drugs, cefepime for injection should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Is Cefepime Cefepime 613 Mg usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?

Cefepime Cefepime 613 Mg safe for breastfeeding
Active ingredient in Cefepime Cefepime 613 Mg is Cefepime and based on our analysis of Cefepime it appears that using Cefepime Cefepime 613 Mg is safe in breastfeeding. Below is analysis of Cefepime while breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Cefepime is excreted in human breast milk. Caution should be exercised when cefepime is administered to a nursing woman [see Clinical Pharmacology ( 12.3)] .

Cefepime Cefepime 613 Mg Breastfeeding Analsys


Cefepime while Breastfeeding

Safe

CAS Number: 123171-59-5

Fourth-generation cephalosporin for injection or parenteral administration. Like most cephalosporins for which data are available, excretion occurs in breast milk in very small amount and it is clinically insignificant (Sanders 1993, Bristol-Myers Squibb 2009). Cephalosporins are widely used in the Pediatric practice with a good tolerance, even in the neonatal period, so it is very unlikely that in small amounts through milk would be a cause of problems in the infant. Be aware of the possibility of false negative results of cultures in febrile infants whose mothers are taking antibiotics as well as the possibility of gastroenteritis (Ito 1993) by altering the intestinal flora.


Cefepime Cefepime 613 Mg Breastfeeding Analsys - 2


Cefepime while Breastfeeding

CAS Number: 88040-23-7

Although no information is available on the use of cefepime during breastfeeding, the levels in breastmilk appear to be low and cephalosporins are generally not be expected to cause adverse effects in breastfed infants. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with cephalosporins, but these effects have not been adequately evaluated. Cefepime is acceptable in nursing mothers.


Cefepime Cefepime 613 Mg and breastfeeding

What should I do if I am breastfeeding mother and I am already exposed to Cefepime Cefepime 613 Mg?

As usage of Cefepime Cefepime 613 Mg is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Cefepime Cefepime 613 Mg else no further action is required.


I am nursing mother and my doctor has suggested me to use Cefepime Cefepime 613 Mg, is it safe?

Usage of Cefepime Cefepime 613 Mg is safe for nursing mothers and baby, No worries.


If I am using Cefepime Cefepime 613 Mg, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Cefepime Cefepime 613 Mg in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week